Bright wellness environment — proactive health screening

Cancer Screening

Proactive Cancer Detection and Prevention

Designed to identify early warning signs of cancer before symptoms appear, our screening offers a proactive approach to protecting your long-term health. Our screenings combine advanced CT imaging, cutting-edge circulating tumor DNA (ctDNA) blood tests, and a suite of state-of-the-art diagnostics and risk-based assessments.

À La Carte Services

Cancer Screening Services

All services are available individually — no package required. Your physician will recommend the right combination based on your health profile and goals.

Prices shown are per individual service. Final services ordered may vary based on your physician's recommendations.

Full Body Scan

30 min

Comprehensive full-body imaging (MRI or CT based on physician recommendation) to screen for tumors, organ abnormalities, and overall organ health.

Mammogram

30 min

Breast cancer screening using low-dose X-ray imaging for early detection.

Breast Ultrasound

30 min

Ultrasound imaging of breast tissue to evaluate abnormalities and complement mammography.

PSA (Prostate-Specific Antigen)

Screens for prostate cancer and monitors prostate health.

CEA (Carcinoembryonic Antigen)

Tumor marker associated with colorectal, lung, and other cancers.

CA-125

Tumor marker used to screen for ovarian cancer and monitor treatment response.

CA 27.29

Tumor marker associated with breast cancer, used for monitoring and early detection.

CA 19-9

Tumor marker used to detect and monitor pancreatic and gastrointestinal cancers.

AFP (Alpha-Fetoprotein)

Tumor marker used to screen for liver cancer and certain germ cell tumors.

HCG (Human Chorionic Gonadotropin)

Tumor marker associated with germ cell tumors and trophoblastic disease.

Galleri (Multi-Cancer ctDNA)

Multi-cancer early detection test using circulating tumor DNA to screen for over 50 types of cancer from a single blood draw.

Cologuard

Non-invasive stool DNA test that detects blood and abnormal DNA markers associated with colon cancer and precancerous polyps.

Genetic Cancer Panel

Screens 81 genes for inherited cancer risk including BRCA1/2, CHEK2, ATM, and others for breast, ovarian, colon, and prostate cancers.

Get Started

Ready to Take the First Step?

Start with an Initial Consultation — your physician will review your health goals and recommend the right screenings for you.